|
FAM21C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.137250E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.251630E-01 |
| Normal-vs-Stage2 |
3.473400E-01 |
| Normal-vs-Stage3 |
6.214600E-01 |
| Normal-vs-Stage4 |
7.938800E-01 |
| Stage1-vs-Stage2 |
9.449000E-01 |
| Stage1-vs-Stage3 |
9.744200E-02 |
| Stage1-vs-Stage4 |
3.455200E-01 |
| Stage2-vs-Stage3 |
2.901400E-01 |
| Stage2-vs-Stage4 |
4.301200E-01 |
| Stage3-vs-Stage4 |
8.873800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.107150E-01 |
| Normal-vs-AfricanAmerican |
1.648250E-01 |
| Normal-vs-Asian |
1.759990E-01 |
| Caucasian-vs-AfricanAmerican |
8.646000E-01 |
| Caucasian-vs-Asian |
7.260100E-02 |
| AfricanAmerican-vs-Asian |
1.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.290800E-01 |
| Normal-vs-Female |
5.556300E-02 |
| Male-vs-Female |
2.259200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.625400E-01 |
| Normal-vs-Extreme_Weight |
5.282600E-01 |
| Normal-vs-Obese |
1.329040E-01 |
| Normal-vs-Extreme_Obese |
2.384800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.498400E-01 |
| Normal_Weight-vs-Obese |
3.582600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.369800E-01 |
| Extreme_Weight-vs-Obese |
3.565200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.344600E-01 |
| Obese-vs-Extreme_Obese |
8.714000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.040170E-01 |
| Normal-vs-Age(41-60Yrs) |
5.119600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.318800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.719600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.047600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.434200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.520400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.272400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.949700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.076300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.270220E-02 |
| Normal-VS-Type2 PRCC |
9.858600E-01 |
| Normal-VS-KIRP CIMP |
8.583100E-03 |
| Normal-VS-Unclassified PRCC |
1.688820E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.101300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.05969999999401E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.583000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.581900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.873800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.060170E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.711400E-01 |
| Normal-vs-N1 |
5.954200E-01 |
| Normal-vs-N2 |
8.384800E-01 |
| N0-vs-N1 |
5.044800E-01 |
| N0-vs-N2 |
7.956200E-01 |
| N1-vs-N2 |
6.483200E-01 |
|
|
